XML 47 R36.htm IDEA: XBRL DOCUMENT

GOODWILL AND INTANGIBLE ASSETS (Tables)

3 Months Ended

Mar. 31, 2022

GOODWILL AND INTANGIBLE ASSETS

Schedule of intangible assets, net

		March 31, 2022				December 31, 2021
Goodwill ⁽¹⁾		$	13,868			$	13,868
Accumulated impairment losses			(2,728	)			-
Goodwill, net		$	11,140			$	13,868

Intangible assets not subject to amortization:
Acquired IPR&D – Chemistry ⁽²⁾		$	502			$	502
Pending patents – Cure Pharmaceutical			342				341
Total intangible assets not subject to amortization			844				843

Intangible assets subject to amortization:
Acquired IPR&D – Chemistry ⁽²⁾			13,958				13,958
Customer relationships ⁽²⁾			7,110				7,110
Tradename ⁽²⁾			2,610				2,610
Noncompete ⁽²⁾			462				462
Intellectual property			972				972
Issued patents			1,034				1,034
Total intangible assets subject to amortization			26,146				26,146
Accumulated amortization			(5,653	)			(4,701	)
Total intangible assets subject to amortization, net			20,493				21,445

Intangible assets, net		$	21,337			$	22,288

Schedule of future amortization expense

2022 (remaining)		$	2,809
2023			3,592
2024			3,429
2025			2,583
2026			1,516
Thereafter			6,564
Total Amortization		$	20,493